IAM Strategy 300 highlights Richard Fagan as a leading IP strategist

2 September 2021

Richard Fagan, Director of BioPharm at UCLB, is highlighted as a leading IP strategist in the IAM Strategy 300 2021. The IAM Strategy 300 identifies the individuals who are leading the way in the development and implementation of strategies that maximise the value of IP portfolios.

Find further details at IAM.